Analyst Report: Solventum Corp

Summary

Solventum has four business segments: MedSurg (56% of 2023 revenue), Dental Solutions (16%), Health Information Systems (16%) and Purification and Filtration (12%). The company is global, with 56% of net sales in 2023 from the Americas, and 44% from international companies. Solventum’s MedSurg segment provides advanced wound care and surgical solutions. Customers include public and private health systems, ambulatory surgical centers, skilled nursing facilities and long-term care facilities. The addressable market for the company in this segment is approximately $26 billion and is growing at a 3%-5% rate. MedSurg’s revenue has been flat over the past three years, with an average operating margin of approximately 23%. Solventum’s Dental Solutions is a provider of a comprehensive suite of restorative, prevention and orthodontic solutions for dentists and orthodontists. The addressable market for the company in this segment is approximately $17 billion and is growing at a 4%-6% rate. Dental Solutions revenue has declined 5% over the past three years, and the average operating margin has been approximately 33%. Solventum’s Health Information Systems (HIS) segment provides software solutions powered by clinical intelligence that create time for clinicians to care for patients and improve accuracy in healthcare reimbursement. Target customer markets include public and private hospitals, physician groups and clinics, federal government agencies and payer organizations. The addressable market for the company in this segment is approximately $9 billion and is growing at a 6%-8% rate. HIS revenue has risen 10% over the past three years, and the average operating margin has been approximately 31%. Solventum’s Purification and Filtration segment provides filter

EMEA Tribune is not involved in this news article, it is taken from our partners and or from the News Agencies. Copyright and Credit go to the News Agencies, email news@emeatribune.com Follow our WhatsApp verified Channel